TABLE I.
Characteristic | CIU-SC (n = 103) | CIU-NSC (n = 52) | P value* |
---|---|---|---|
Age (y), mean ± SD, y | 41.4 ± 13.8 | 45.9 ± 13.1 | .05 |
Sex: female, % | 68.9 | 69.2 | .97 |
White, % | 79.6 | 78.9 | .95 |
Disease duration >4 y, % | 51.5 | 30.8 | .01 |
Number of corticosteroid taper in the past 1 y, mean ± SD | 1.6 ± 1.3 | 0.9 ± 1.2 | .002 |
Number of corticosteroid taper in CIU lifetime, mean ± SD | 2.3 ± 1.1 | 1.6 ± 1.3 | <.001 |
> 1 visit to the ED for CIU in the past 1 y, % | 41.7 | 23.1 | <.001 |
> 1 d of work or school absence in CIU lifetime, % | 65 | 27.5 | <.001 |
Oral corticosteroids used for CIU, % | 84.5 | 59.6 | .002 |
Antihistamines used for CIU, % | 99 | 100 | .32 |
Antileukotrienes used for CIU, % | 45.6 | 38.5 | .40 |
Antidepressants used for CIU, % | 54.4 | 40.4 | .10 |
ED, Emergency department.
CIU-SC vs CIU-NSC.